Corpus Christi Radiation Oncology Center P A Corpus Christi, TX - 78418

Corpus Christi Radiation Oncology Center P A is categorized under Oncologists in Corpus Christi, TX and active since 2008.

Corpus Christi Radiation Oncology Center P A was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Molly Gillespie at the company’s single location by writing to 15325 Yardarm Court, Corpus Christi, Texas TX 78418 or by phoning (361) 816-1763. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Corpus Christi Radiation Oncology Center P A
Contact Person: Molly Gillespie
Address: 15325 Yardarm Court, Corpus Christi, Texas 78418
Phone Number: (361) 816-1763
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Corpus Christi Radiation Oncology Center P A was started in 2008 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Molly Gillespie for inquiries that concern Corpus Christi Radiation Oncology Center P A by calling the company number (361) 816-1763, as your correspondence is most welcome. Additionally, the physical location of the single location of Corpus Christi Radiation Oncology Center P A can be found at the coordinates 27.601449,-97.236239 as well as the street address 15325 Yardarm Court in Corpus Christi, Texas 78418.

For its online presence, you may visit Corpus Christi Radiation Oncology Center P A’s website at and engage with its social media outlets through on Twitter and on Facebook.